Internationale Publikationen
Hier stellen wir eine Auswahl wissenschaftlicher Veröffentlichungen zur Verfügung, die im Zusammenhang mit der IOZK-Immuntherapie stehen.
Sie können mit Hilfe der Filter eine Auswahl nach Tumorarten und Methoden treffen, oder Suchbegriffe eingeben.
The feasibility and clinical effects of dendritic cell-based immunotherapy targeting synthesized peptides for recurrent ovarian cancer
Wilms‘ tumor gene 1 immunotherapy in pelvic gynecological malignancies
Immunotherapy for high-grade glioma
Adoptive cellular immunotherapy for the treatment of patients with breast cancer: a meta-analysis
Prognostic factors related to add-on dendritic cell vaccines on patients with inoperable pancreatic cancer receiving chemotherapy: a multicenter analysis
Colorectal cancer and immunity: what we know and perspectives
SnapShot: cancer vaccines
Current status of oncothermia therapy for lung cancer
Autologous tumor lysate-pulsed dendritic cell immunotherapy with cytokine-induced killer cells improves survival in gastric and colorectal cancer patients
Current vaccine trials in glioblastoma: a review
Oncolytic viruses and their application to cancer immunotherapy
Gene expression profiling in PC12 cells infected with an oncolytic Newcastle disease virus strain
Viruses for tumor therapy
Genetically engineered Newcastle disease virus expressing interleukin 2 is a potential drug candidate for cancer immunotherapy
Localized oncolytic virotherapy overcomes systemic tumor resistance to immune checkpoint blockade immunotherapy
Natural killer cells: the secret weapon in dendritic cell vaccination strategies
Novel approaches and mechanisms of immunotherapy for glioblastoma
Phase I dendritic cell p53 peptide vaccine for head and neck cancer
Dasatinib promotes the expansion of a therapeutically superior T-cell repertoire in response to dendritic cell vaccination against melanoma
DNA fragmentation and caspase-independent programmed cell death by modulated electrohyperthermia